← Medication & Supplement Reference

VETERINARY TEAM REFERENCE · MEDICATION

Spinosad + milbemycin oxime

Updated October 27, 2026 · Sources and review status below

For veterinarians and veterinary staff. Product-label information is distinct from extra-label clinical practice. This is not a complete prescribing formulary or an automated interaction screen. Verify the current label, exact formulation, patient and species-specific clinical reference before use. Independent veterinary/pharmacy review remains pending.

Prescribing overview

Canine flea, heartworm-prevention and intestinal-nematode combination.

Combination antiparasiticProduct-specific clinical reference

A dog-only combination; constituent products cannot substitute for its complete parasite coverage.

Key prescribing checks

  • Review the full product-specific safety section and the patient’s complete treatment plan.

Uses by species

Approval and evidence apply to the named product, species, route and indication. An extra-label use requires its own prescribing assessment; a human indication is not an animal approval.

Dogs

US veterinary product label

Heartworm prevention, fleas and specified adult hookworms, roundworms and whipworms

Patient and indication restrictions apply.

Use / indication source ↗

Pharmacology & pharmacokinetics

Mechanism and clinical role

Spinosad activates insect nicotinic receptors; milbemycin affects invertebrate chloride channels.

Absorption, distribution, metabolism and elimination

Food supports product effectiveness; quantitative combination kinetics are not established here.

SAFETY REFERENCE · PRODUCT & SPECIES SPECIFIC

Contraindications & cautions

Contraindications identify circumstances where the source says a product should not be used. Precautions call for assessment or monitoring. Interactions identify combinations to review. They are distinct categories; this summary does not replace a full interaction check or the current product label.

Trifexis

US Canine chewable tablet label.

Contraindications · when not to use

  • The label lists no known contraindications.

Precautions & monitoring

  • Caution with epilepsy/breeding females; breeding-male safety is unestablished. Test for heartworm before starting.

Selected safety information; not a complete interaction assessment.

Safety sources checked: . Selected label information; independent veterinary or veterinary-pharmacy review remains pending. A label for dogs, cats, horses or humans does not establish safety for another species.

Adverse effects

Vomiting, lethargy, itching, appetite loss and diarrhea occur; neurologic reactions are reported.

These are selected source-reported effects, not incidence estimates or an exhaustive list. Spontaneous postmarketing reports do not by themselves establish frequency or causality.

Dosing & administration

Verify the source before prescribing. The regimens below summarize selected veterinary product labels, not every accepted veterinary use. They are not automatic substitutions between brands or formulations. Renal/hepatic disease, concurrent therapy, age, indication and clinical response can require a different plan.

A verified veterinary dose has not been entered for this product. Human-label dosing must not be used as an animal regimen. Consult a current species-specific clinical source and the prescribing veterinarian.

Select a regimen from the current exact-product label with the prescribing veterinarian; no calculator regimen is supplied for this entry.

Extra-label prescribing and food-animal residue requirements are separate from labeled regimens. FDA extra-label-use guidance ↗

Drug & supplement interactions

This monograph summarizes selected interactions. The comparison tool applies a curated set of rules and is not comprehensive. Reconcile prescription drugs, nonprescription products, supplements and recent treatment changes.

Compare with other medications and check species →

Trifexis

US Canine chewable tablet label.

  • Serious reactions have followed extra-label ivermectin with spinosad.
Interaction source ↗Interaction source ↗

Monitoring

Observe for vomiting, neurologic changes and ongoing parasite exposure.

Client counseling

Give with food. Confirm age/weight eligibility and the prescriber’s missed-dose/vomiting plan. Not an adult-heartworm treatment.

This section supports the veterinary team's discharge discussion; it does not replace the product’s Client Information Sheet where one is required.

Storage & handling

Store in the labeled room-temperature range.

Brands, formulations & ingredient identity

Active ingredients

Spinosad · Milbemycin oxime

Other searchable names: Trifexis · Milbemycin oxime + spinosad

This reference covers the named US product and route; other formulations need separate verification.

Shared ingredients do not establish interchangeable concentrations, routes, release properties, species labeling or regional availability.

Trifexis

Formulation
Canine chewable tablet
Label / product scope
Dogs

US labeled presentation; verify the current package.

Product label / source ↗

References & review status

Clinical reference updated October 27, 2026. Independent veterinary or veterinary-pharmacy review not yet completed. Evidence gaps remain explicitly identified; this page does not claim equivalence to a comprehensive, professionally reviewed veterinary formulary.

Search another medication or supplement →

CONTINUE EXPLORING

Use these connected guides to prepare informed questions for your veterinary team.

Find Veterinary Care Near YouLocate general practices, urgent-care clinics, emergency hospitals and specialists.Read resource →When It Is an EmergencyRecognize signs that require immediate veterinary care.Read resource →Interactive Symptom NavigatorStart with what you notice and understand when to seek help.Read resource →Poisons and Household HazardsRecognize common exposures and avoid unsafe home treatment.Read resource →Printable Owner ToolkitBring observations, medication details and questions to your appointment.Read resource →
Privacy & cookie choices